Glycosylation States of Pre- and Post-synaptic Markers of 5-HT Neurons Differ With Sex and 5-HTTLPR Genotype in Cortical Autopsy Samples

Frontiers in Neuroscience
Jennifer N K NyarkoDarrell D Mousseau

Abstract

The serotonin (5-hydroxytryptamine, 5-HT) transporter (5-HTT) gene-linked polymorphic region (5-HTTLPR) is thought to alter 5-HT signaling and contribute to behavioral and cognitive phenotypes in depression as well as Alzheimer disease (AD). We explored how well the short (S) and long (L) alleles of the 5-HTTLPR align with serotoninergic indices in 60 autopsied cortical samples from early-onset AD/EOAD and late-onset AD/LOAD donors, and age- and sex-matched controls. Stratifying data by either diagnosis-by-genotype or by sex-by-genotype revealed that the donor's 5-HTTLPR genotype, i.e., L/L, S/L, or S/S, did not affect 5-HTT mRNA or protein expression. However, the glycosylation of 5-HTT was significantly higher in control female (vs. male) samples and tended to decrease in female EOAD/LOAD samples, but remained unaltered in male LOAD samples. Glycosylated forms of the vesicular monoamine transporter (VMAT2) were lower in both male and female AD samples, while a sex-by-genotype stratification revealed a loss of VMAT2 glycosylation specifically in females with an L/L genotype. VMAT2 and 5-HTT glycosylation were correlated in male samples and inversely correlated in female samples in both stratification models. The S/S genotype a...Continue Reading

References

Feb 1, 1986·Psychiatry Research·J Davidson, S Pelton
Aug 1, 1988·Annals of Neurology·R M ZweigD L Price
Sep 18, 1993·Lancet·J PoirierS Gauthier
Sep 24, 1993·Annals of the New York Academy of Sciences·G Richter-Levin, M Segal
Jun 1, 1996·Journal of Neurochemistry·A HeilsK P Lesch
Nov 1, 1995·Brain Research. Molecular Brain Research·J R BackstromE Sanders-Bush
Nov 5, 1997·Advances in Pharmacology·J P HenryB Gasnier
Oct 12, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·B G PollockD J Kupfer
Dec 21, 2000·Neuropathology and Applied Neurobiology·U RübH Braak
Feb 24, 2001·Annals of Neurology·J ParviziA Damasio
Dec 14, 2002·Lancet·Karen Ritchie, Simon Lovestone
Mar 3, 2004·The American Journal of Psychiatry·Christopher H van DyckJoel Gelernter
Sep 28, 2005·Journal of Molecular Neuroscience : MN·Agnes L NishimuraMayana Zatz
Sep 9, 2006·Cell·Kazuaki Ohtsubo, Jamey D Marth
Oct 26, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Jorge A CervillaUNKNOWN PREDICT Study Core Group
Jun 22, 2007·Neurobiology of Aging·Ignacio Cruz-MurosTomás González-Hernández
Dec 7, 2007·International Journal of Geriatric Psychiatry·Lisa Delano-WoodMark W Bondi
Dec 17, 2008·Trends in Pharmacological Sciences·Madeleine V KingKevin C F Fone
Dec 19, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ying LiuMichael K Lee
Dec 30, 2008·Brain Research Bulletin·Régis GrailheIsabelle Cloëz-Tayarani
Jan 14, 2009·Journal of Affective Disorders·Lars Vedel KessingPer Kragh Andersen

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
PCR
genotyping
confocal microscopy

Software Mentioned

ImageJ
Image J

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.